CDK6 and ovarian carcinoma: An increasing number of studies have shown that the aberrant expression of CDK6 is closely associated with the occurrence and development of many cancers, including breast cancer [27], ovarian cancer [28], colon cancer [29], bladder cancer [30, 31] and more [32, 33].